Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In LaxouThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In BoharsThis study is recruiting in China. It is testing Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules for Schizophrenia.
In Beijing
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In China
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In TianjinThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Switzerland.
In BaselThis study is recruiting in the United States. It is testing Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia.
Multiple locations, including Bentonville
This study is recruiting in the United States. It is testing roluperidone for schizophrenia.
Multiple locations, including GaithersburgThis study is recruiting in the United States. It is testing LB-102 for schizophrenia.
Multiple locations, including BentonvilleThis study is recruiting in the United States, in Argentina, in Brazil, .... It is testing weight Gain for schizophrenia.
Multiple locations, including DothanThis study is recruiting in Netherlands. It focuses on Schizophrenia.
In NetherlandsThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Pakistan.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.